Palvella Therapeutics, Inc
Price
FilingsNewest: 13G, Stake over 5%, passiveAug 10 →Insiders2 insiders bought $849,974 in 3 open-market buys. 1 insider sold $3.6M, all 21 sales on a 10b5-1 plan.→HoldersMontanova Capital 7.9%Jennison Associates 6.7%BlackRock 6.4%→Financing →PeersClosest companies: RAPP, MBX, SEPN→
From the filings
Figures
- Net income
- −$61.7Mlast 12 months
- Operating cash flow
- −$29.1Mlast 12 months
- Cash and equivalents
- $187.8Mat the last balance sheet
- Shares outstanding
- 14.4M shareson issue